Victory RS Value A holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Victory RS Value Fund Class A RSVAX
- NAV / 1-Day Return 27.25 / +0.52 %
- Total Assets 263.5M
-
Adj. Expense Ratio
1.300%
- Expense Ratio 1.300%
- Distribution Fee Level High
- Share Class Type Front Load
- Category Mid-Cap Value
- Investment Style Mid Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.55%
- Turnover 50%
USD | NAV as of Aug 08, 2026 | 1-Day Return as of Aug 08, 2026, 12:11 AM GMT+0
Morningstar’s Analysis RSVAX
Will RSVAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 27.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Globe Life Inc | 4.51 | 11M | Financial Services |
Teva Pharmaceutical Industries Ltd ADR | 3.13 | 8M | Healthcare |
FirstEnergy Corp | 2.79 | 7M | Utilities |
AMETEK Inc | 2.77 | 7M | Industrials |
NNN REIT Inc | 2.63 | 6M | Real Estate |
CenterPoint Energy Inc | 2.50 | 6M | Utilities |
Dover Corp | 2.44 | 6M | Industrials |
MarketAxess Holdings Inc | 2.27 | 6M | Financial Services |
The Timken Co | 2.25 | 6M | Industrials |
Littelfuse Inc | 2.19 | 5M | Technology |